Featured Intelligence

Successfully Navigating the Seas of Competitive Intelligence in Life Sciences

Interactive E-Book

In life sciences, we are all swimming in a sea of information. We have access to a staggering amount of data that was unimaginable even 5 years ago—and demand for data and information remains high even with the recent economic slowdown. As there is more information in biopharma available than ever before, it becomes increasingly harder to sift through that information and find actionable competitive intelligence.

Read Now

Home / Intelligence

Type
  • All
  • Blog
  • Briefs
  • Case Studies
  • Industry Publications
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Search

Successfully Navigating the Seas of Competitive Intelligence in Life Sciences

In life sciences, we are all swimming in a sea of information. We have access to a staggering amount of data that was unimaginable even 5 years ago—and demand for data and information remains high even with the recent economic slowdown. Consider this: ClinicalTrials.gov lists more than 400,000 studies worldwide in 2022, compared to about 2,000 in the year 2000. Over the past decade, the number of medical publications has grown by 86%. The number of pharma and biotech company…

Read Now

What Leaders in Life Sciences Need to Know to be Prepared for 2023

Host and President of TGaS Advisors, Gary McWalters, joins a panel of four experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the key themes that were discussed at the TGaS Fall Client Summit – an annual event that brings together leaders in life sciences to discuss innovative solutions to the common challenges faced within commercial operations.   Featuring HOST: Gary McWaltersHost and President of TGaS Advisors Kim WoodhourField Operations Director Brian VoellmeckeCommercial Data Management Leader Jim…

Listen Now

Cracking the Code of the Access Landscape in China

As the market becomes increasingly crowded and budget constraints continue in China, downward pricing pressure to secure National Reimbursement Drug List (NRDL) inclusion remains the top challenge for multinational pharma companies in this market. However, the significant uptake post-NRDL inclusion and broad access offer substantial opportunities for innovative products with clinical differentiation.   In this white paper, Trinity Life Sciences explores the highlights of the 2021 NRDL negotiation; including trends within the oncology, rare disease and chronic disease therapeutic areas…

Read Now

How to Lead and Develop High-Performing Field Matrix Teams

Many life sciences companies design customer engagement models that rely on coordination and communication between Account Managers, Sales, Reimbursement, Patient Services, and Field Medical to drive outcomes, performance, continuity and improve the customer and patient experience. These collaborative field teams are often formally or informally referred to as matrix or matrix-based field teams, and tend to be organized by Integrated Delivery Networks (IDNs), ecosystems and/or geography. Executive stakeholders from Field Leadership, Brands and Market Access functions have shared during benchmark…

Read Now

2022 Annual Digital Marketing Competency Report

Market Dynamics  During the past two years we have witnessed an accelerating race to evolve digital and data capabilities through enhancement of tech stacks to make organizations more analytically driven and connected moving forward. With issues such as data privacy and a cookie-less world at the forefront, it is now incumbent upon brands to unify data and to understand how independent efforts come together to impact customers.  TGaS Approach  At TGaS/Trinity Life Sciences, the Omnichannel Solution is deeply connected across…

Read Now

What You Need to Know to Be Prepared for 2023

This advisory brief incorporates learnings from TGaS Advisors’ 2022 Fall Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges. More than 200 individuals from 100 emerging, mid-tier and large-tier biopharmaceutical companies attended function-specific sessions across the Commercial, Market Access and Medical Affairs ecosystem. Leaders shared perspectives, made recommendations and collectively thought through alternative paths forward relative to key decisions to be made…

Read Now

The Enhancing Oncology Care Model: Where Public Health Meets Oncology Care

November 7, 2022 Executive Summary The Oncology Care Model (OCM) was designed to test whether financial incentives can improve care and lower Medicare (U.S. federal health insurance program) spending, emphasizing value-based care within oncology treatment. This model supported a wide range of services such as high-cost emergency room visits, 24/7 access to clinicians and specialized, patient-specific coordinated care plans.The Enhancing Oncology Model (EOM) builds on the structure of OCM with an increased focus on managing provider risk, promoting patient-centric care…

Read Now

Business Development: Getting Pricing & Access Inputs Right

Now Available On Demand: Trinity invites life sciences executives to join us for a dynamic discussion on the most common high-impact challenges inherent in Business Development: What contributes to inaccurate pricing and market access assumptions in the quick-paced Business Development process? How do you de-risk pricing and access at each stage of the diligence process? Chad Faulkner, Partner in Trinity’s Strategic Advisory practice, will host this session and moderate a panel with special guests Monica Martin De Bustamante—Senior Partner &…

Watch Now

Incentive Compensation: Keys to Success in the Quest for Talent

Now Available On Demand: What are the latest incentive compensation trends that you need to know to remain competitive in the quest for talent? TGaS Advisors, a division of Trinity Life Sciences, explored this question as part of our 12th Annual Incentive Compensation Landscape – the most comprehensive study of its kind in the life sciences industry. We surveyed Incentive Compensation (IC) leaders at 54 life sciences companies of all sizes to gain their perspectives on current trends and best…

Watch Now

The German Financial Stabilization of Statutory Health Insurance System Act

October 31, 2022 Executive Summary: Germany’s ‘Financial Stabilization of Statutory Health Insurance System’ Act (GKV-Finanzstabilisierungsgesetz) was first proposed in March 2022 by Health Minister Professor Karl Lauterbach to help tackle the country’s economic deficit As of October 2022, the act was adopted by the Bundestag (German Federal Parliament). The act is expected to be implemented by January 2023 The new Statutory Health Stabilization Act includes several measures with significant impact in the commercial opportunity for pharmaceutical products Key Policy Updates…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.